Wells Fargo & Company Cel Sci Corp Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Cel Sci Corp stock. As of the latest transaction made, Wells Fargo & Company holds 20,028 shares of CVM stock, worth $14,019. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,028

Previous 19,028 5.26%

Holding current value

$14,019

Previous $22,000 4.55%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.05 - $1.5 $1,050 - $1,500	1,000 Added 5.26%	20,028 $21,000
Q2 2024 Aug 13, 2024	BUY	$1.11 - $1.85 $419 - $699	378 Added 2.03%	19,028 $22,000
Q1 2024 May 10, 2024	BUY	$1.63 - $3.08 $1,724 - $3,258	1,058 Added 6.01%	18,650 $35,000
Q4 2023 Feb 09, 2024	BUY	$1.07 - $3.07 $2,160 - $6,198	2,019 Added 12.96%	17,592 $47,000
Q3 2023 Nov 13, 2023	BUY	$1.17 - $2.86 $4,469 - $10,925	3,820 Added 32.5%	15,573 $19,000
Q2 2023 Aug 15, 2023	BUY	$2.11 - $2.83 $470 - $631	223 Added 1.93%	11,753 $28,000
Q1 2023 May 12, 2023	BUY	$2.17 - $3.13 $13 - $18	6 Added 0.05%	11,530 $26,000
Q4 2022 Feb 13, 2023	BUY	$1.99 - $3.52 $13 - $24	7 Added 0.06%	11,524 $27,000
Q3 2022 Nov 14, 2022	BUY	$3.09 - $5.23 $3,083 - $5,219	998 Added 9.49%	11,517 $35,000
Q2 2022 Aug 12, 2022	SELL	$2.58 - $4.99 $7,242 - $14,006	-2,807 Reduced 21.06%	10,519 $48,000
Q1 2022 May 16, 2022	SELL	$3.93 - $7.7 $49,447 - $96,881	-12,582 Reduced 48.56%	13,326 $53,000
Q4 2021 Feb 14, 2022	BUY	$7.1 - $12.82 $157,059 - $283,591	22,121 Added 584.13%	25,908 $185,000
Q3 2021 Nov 15, 2021	SELL	$7.64 - $12.49 $19,092 - $31,212	-2,499 Reduced 39.76%	3,787 $41,000
Q2 2021 Aug 16, 2021	SELL	$8.68 - $27.49 $5,312 - $16,823	-612 Reduced 8.87%	6,286 $55,000
Q1 2021 May 13, 2021	SELL	$12.0 - $27.64 $921,240 - $2.12 Million	-76,770 Reduced 91.76%	6,898 $105,000
Q4 2020 Feb 09, 2021	BUY	$11.05 - $16.62 $30,221 - $45,455	2,735 Added 3.38%	83,668 $975,000
Q3 2020 Nov 05, 2020	SELL	$11.69 - $14.54 $160,445 - $199,561	-13,725 Reduced 14.5%	80,933 $1.03 Million
Q2 2020 Aug 13, 2020	BUY	$9.75 - $17.6 $225,039 - $406,225	23,081 Added 32.25%	94,658 $1.41 Million
Q1 2020 May 14, 2020	BUY	$7.54 - $17.05 $539,690 - $1.22 Million	71,577 New	71,577 $826,000

Others Institutions Holding CVM

# of Institutions

Shares Held

Call Options Held

27.1K

Put Options Held

150K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $30.4M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Cel Sci Corp Transaction History